MaxLinear (MXL) Tops Q3 EPS by 3c

MaxLinear (NYSE: MXL) reported Q3 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $96.3 million versus the consensus estimate of $95.89 million.

GUIDANCE:

MaxLinear sees Q4 2016 revenue of $85-89 million, versus the consensus of $88.2 million.

For earnings history and earnings-related data on MaxLinear (MXL) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• Associated Banc-Corp (ASB) Tops Q1 EPS by 3c